B. Douglas Hoey

1 week ago | drugtopics.com | Killian Meara |B. Douglas Hoey

Rite Aid, which was once one of the largest pharmacy chains in the United States, recently announced it has filed its second Chapter 11 bankruptcy and will be closing all of its stores or selling them.1 The company, which has continued to face financial hardships since filing for its first Chapter 11 bankruptcy in 2023, said its stores will remain open for the next few months so that patients can continue to receive care.

2 weeks ago | drugtopics.com | Killian Meara |B. Douglas Hoey

Over 300 US pharmacies have closed since December 2024, largely due to pharmacy benefit managers and stalled legislative reform, according to the American Economic Liberties Project.1 Independent pharmacies, critical in many communities, need to adapt to survive. Douglas Hoey, RPh, MBA, CEO of the National Community Pharmacists Association (NCPA), said many are turning to niche services like long-term care at home.

2 weeks ago | drugtopics.com | Killian Meara |B. Douglas Hoey

The Medicare Drug Price Negotiation Program, introduced under the Inflation Reduction Act, allows the Centers for Medicare and Medicaid Services (CMS) to negotiate the prices of certain high-cost brand-name drugs in Medicare Part B and Part D.

4 weeks ago | drugtopics.com | Killian Meara |B. Douglas Hoey

Community pharmacy closures are accelerating across the United States. According to an analysis from the American Economic Liberties Project, over 300 pharmacies have shut their doors since late December 2024.1 The authors of that analysis laid the blame largely on pharmacy benefit managers (PBM) and a lack of reform from Congress. Independent pharmacies, which provide critical access to health care in many communities, are now being forced to adapt quickly to survive.

1 month ago | drugtopics.com | Killian Meara |B. Douglas Hoey

Despite repeated promises, Congress has continued to delay pharmacy benefit manager (PBM) reform, leaving independent pharmacies in crisis. With a new administration in the White House that has signaled support for PBM reform, there is renewed hope for change. However, Douglas Hoey, RPh, MBA, CEO of the National Community Pharmacists Association (NCPA), warns that while there is optimism, patience is wearing thin—the time for meaningful reform is now.